Peggy Pinkston | VP, IR |
Clay Siegall | President & CEO |
Roger Dansey | Chief Medical Officer |
Todd Simpson | CFO |
Michael Schmidt | Guggenheim |
Kennen MacKay | RBC Capital Markets |
Cory Kasimov | JP Morgan |
Jeff Meacham | Barclays |
Salveen Richter | Goldman Sachs |
Andrew Berens | SVB |
Tazeen Ahmad | Bank of America |
Steven Wiley | Stifel |
Shanshan Xu | Berenberg Capital Markets |
Silvan Tuerkcan | Oppenheimer |
Good day, and welcome to the Seattle Genetics First Quarter 2019 Financial Results. Today's conference is being recorded. At this time, I would like to turn the conference over to Peggy Pinkston, Vice President, Investor Relations. Please go ahead sir ma'am.
Thank you, operator and good afternoon everyone.